At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GSK GlaxoSmithKline PLC
Post-Mkt 02-23 19:19:54 EST
59.26
-0.26
-0.44%
盘后59.05
-0.21-0.35%
19:15 EST
High59.71Low59.02Vol6.85M
Open59.27D1 Closing59.52Amplitude1.16%
Mkt Cap120.77BTradable Cap115.37BTotal Shares2.04B
T/O406.54MT/O Rate0.35%Tradable Shares1.95B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

GSK, Bora Pharmaceuticals Extend Five-Year Manufacturing Alliance
MT Newswires Live  ·  02:50
GSK, Bora Pharmaceuticals Extend Five-Year Manufacturing Alliance
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
Reuters  ·  01:09
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
Frontier Biotechnologies Inks Licensing Agreement with GSK for siRNA Pipeline
Stock News  ·  02-23 17:03
Frontier Biotechnologies Inks Licensing Agreement with GSK for siRNA Pipeline
GSK price target raised to 1,900 GBp from 1,780 GBp at Barclays
TIPRANKS  ·  02-21
GSK price target raised to 1,900 GBp from 1,780 GBp at Barclays
GSK Director Wendy Becker Increases Stake with Share Purchase
TIPRANKS  ·  02-20
GSK Director Wendy Becker Increases Stake with Share Purchase
GlaxoSmithKline (GSK) Gets a Sell from Barclays
TIPRANKS  ·  02-20
GlaxoSmithKline (GSK) Gets a Sell from Barclays
GSK lifts treasury stake with latest £10.5m share buyback
TIPRANKS  ·  02-20
GSK lifts treasury stake with latest £10.5m share buyback
GSK Reports Deferred Award Payout to Chief Scientific Officer Tony Wood
TIPRANKS  ·  02-19
GSK Reports Deferred Award Payout to Chief Scientific Officer Tony Wood
GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank
TIPRANKS  ·  02-19
GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank
ViiV Healthcare says Cabenuva demonstrated superior efficacy in LATITUDE trial
TIPRANKS  ·  02-19
ViiV Healthcare says Cabenuva demonstrated superior efficacy in LATITUDE trial
GSK Adds 420,000 Shares to Treasury in Latest Buyback
TIPRANKS  ·  02-18
GSK Adds 420,000 Shares to Treasury in Latest Buyback
GSK Rises Tuesday, Outperforms Market
Dow Jones  ·  02-18
GSK Rises Tuesday, Outperforms Market
European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Tuesday Trading
MT Newswires Live  ·  02-17
European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Tuesday Trading
GSK Discloses ADS Vesting and Tax-Related Share Sale by U.S. President
TIPRANKS  ·  02-17
GSK Discloses ADS Vesting and Tax-Related Share Sale by U.S. President
GSK executive awards vest at 82% after strong sales, profit and ESG performance
TIPRANKS  ·  02-17
GSK executive awards vest at 82% after strong sales, profit and ESG performance
GSK Says European Commission Approved Exdensur as Add-on Severe Asthma, Chronic Rhinosinusitis Treatment
MT Newswires Live  ·  02-17
GSK Says European Commission Approved Exdensur as Add-on Severe Asthma, Chronic Rhinosinusitis Treatment
GSK’s announces new data for Arexvy at RSVVW’26
TIPRANKS  ·  02-17
GSK’s announces new data for Arexvy at RSVVW’26
Europe Clears GSK's New Twice-Yearly Asthma Treatment
Benzinga_recent_news  ·  02-17
Europe Clears GSK's New Twice-Yearly Asthma Treatment
Berenberg Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
TIPRANKS  ·  02-17
Berenberg Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
GSK Wins EU Nod for First Ultra-Long-Acting Biologic in Severe Asthma
TIPRANKS  ·  02-17
GSK Wins EU Nod for First Ultra-Long-Acting Biologic in Severe Asthma

Introduction

Company Name.
GlaxoSmithKline PLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Issue price:
--